Skip to main content
OpenTrials

Clinical trial condition

Urologic Diseases

Explore clinical trials studying Urologic Diseases. Study availability and eligibility vary by location and protocol.

13,592 public trials 2,146 recruiting studies
Refine in advanced search Browse all conditions

Urologic Diseases trial results

Recruiting

A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)

NCT07419295

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Munson Medical Center ( Site 0812) Traverse City, Michigan, United States
  • TriHealth Cancer Institute-Good Samaritan Hospital ( Site 0822) Cincinnati, Ohio, United States
  • The West Clinic, P.C. ( Site 0791) Germantown, Tennessee, United States
  • Thompson Cancer Survival Center ( Site 0803) Knoxville, Tennessee, United States
View all 71 locations
View Trial Details
Recruiting

Phase 1 Study to Evaluate the Safety and Tolerability of Intravenously Administered PYC-003

NCT06714006

Conditions
Abnormalities, Multiple, Autosomal Dominant Polycystic Kidney Disease (ADPKD), Ciliopathies, +12 more
Locations
  • South Coast Renal, Brockway House, Level 1, Suite 8, 82-86 Queen Street, Southport, Gold Coast, Australia
  • Concord Repatriation General Hospital Concord, New South Wales, Australia
  • Liverpool Hospital, Clinic G-Reception 133, Level 1, Clinical Building, Burnside Drive Liverpool, New South Wales, Australia
  • Scientia Clinical Research Randwick, New South Wales, Australia
View Trial Details
Recruiting

A Study to Evaluate Mosunetuzumab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis

NCT07598396

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +13 more
Locations
  • Clnica SER da Bahia Salvador, Estado de Bahia, Brazil
  • L2IP ?Instituto de Pesquisas Clínicas Ltda. Brasília, Federal District, Brazil
  • IPC MT Instituto de Pesquisas Clinicas do Mato Grosso Cuiab, Mato Grosso, Brazil
  • Complexo Hospitalar de Niteroi Niterói, Rio de Janeiro, Brazil
View all 17 locations
View Trial Details
Recruiting

A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)

NCT07489495

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
Locations
  • Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital ( Site 0102) Marietta, Georgia, United States
  • The West Clinic, P.C. ( Site 0115) Germantown, Tennessee, United States
  • Centro Oncologico Korben ( Site 0254) CABA, Buenos Aires, Argentina
  • Hospital Italiano de Buenos Aires ( Site 0253) Ciudad de Buenos Aires, Buenos Aires, Argentina
View all 66 locations
View Trial Details
Recruiting

Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease

NCT06989359

Conditions
Autoimmune Diseases, C3G, Complement-mediated Kidney Disease, +13 more
Locations
  • ADARx Clinical Site Doral, Florida, United States
  • ADARx Clinical Site Miami, Florida, United States
  • ADARx Clinical Site Pembroke Pines, Florida, United States
  • ADARx Clinical Site Iowa City, Iowa, United States
View all 34 locations
View Trial Details
Recruiting

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

NCT05503797

Conditions
Adenocarcinoma, Adnexal Diseases, Biliary Tract Diseases, +52 more
Locations
  • Precision NextGen Oncology & Research Center Beverly Hills, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • University of California Los Angeles Rheumatology Westwood, Los Angeles, California, United States
  • Norwalk Hospital Norwalk, Connecticut, United States
View all 70 locations
View Trial Details
Recruiting

Pivotal Study of the Velocity™ pAVF System

NCT07153939

Conditions
Arteriovenous Fistula, Arteriovenous Malformations, Cardiovascular Abnormalities, +24 more
Locations
  • Trinity Research Group Dothan, Alabama, United States
  • West Coast Kidney Institute Concord Concord, California, United States
  • Apex Research Riverside, California, United States
  • Vascular and Embolization Specialists Cocoa, Florida, United States
View Trial Details

Related conditions